Licence for Botox in so-called chronic migraine

被引：12

作者：

Olesen, Jes ^{[1
]}

Tfelt-Hansen, Peer ^{[1
]}

机构：

[1] Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, DK-2600 Glostrup, Denmark

来源：

LANCET | 2010年 / 376卷 / 9755期

关键词：

PLACEBO-CONTROLLED PHASE; DOUBLE-BLIND; ONABOTULINUMTOXINA;

D O I：

10.1016/S0140-6736(10)62165-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1825 / 1826

页数：2

共 5 条

[1]

Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676

[2] OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [J].

Diener, H. C. ;

Dodick, D. W. ;

Aurora, S. K. ;

Turkel, C. C. ;

DeGryse, R. E. ;

Lipton, R. B. ;

Silberstein, S. D. ;

Brin, M. F. .

CEPHALALGIA, 2010, 30 (07) :804-814

[3] OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program [J].

Dodick, David W. ;

Turkel, Catherine C. ;

DeGryse, Ronald E. ;

Aurora, Sheena K. ;

Silberstein, Stephen D. ;

Lipton, Richard B. ;

Diener, Hans-Christoph ;

Brin, Mitchell F. .

HEADACHE, 2010, 50 (06) :921-936

[4] Botulinum toxin in headache treatment: the end of the road? [J].

Evers, S. ;

Olesen, J. .

CEPHALALGIA, 2006, 26 (07) :769-771

[5] Migraine pathophysiology and its clinical implications [J].

Silberstein, SD .

CEPHALALGIA, 2004, 24 :2-7

← 1 →